Exploring gene function and drug action using chemogenomic dosage assays

Methods in Enzymology

Volumn 470, Issue C, 2010, Pages 233-255

  Ericson, Elke ^a,b,c   Hoon, Shawn ^d,e   St Onge, Robert P ^d   Giaever, Guri ^a,b   Nislow, Corey ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ASTRAZENECA R AND D   (Sweden)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Agency for Science   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; DNA; GLYCEROL; PHYCOERYTHRIN; RNA; STREPTAVIDIN; URACIL; WATER;

AIR; ALLELE; ARTICLE; CELL ASSAY; CELL FUNCTION; CELL GROWTH; CELL SUSPENSION; DNA HYBRIDIZATION; DRUG DNA INTERACTION; DRUG MECHANISM; ESCHERICHIA COLI; FUNGAL GENE; FUNGUS GROWTH; GENE AMPLIFICATION; GENE CONSTRUCT; GENE DELETION; GENE DOSAGE; GENE FUNCTION; GENE INTERACTION; GENE LIBRARY; GENE REPLICATION; GROWTH RATE; HETEROZYGOTE; INOCULATION; INSTRUMENT STERILIZATION; MICROARRAY ANALYSIS; NONHUMAN; OPEN READING FRAME; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ROOM TEMPERATURE; SCHIZOSACCHAROMYCES POMBE; SPECTROPHOTOMETER; THAWING; ULTRAVIOLET SPECTROPHOTOMETRY; WILD TYPE; YEAST;

SACCHAROMYCES CEREVISIAE;

EID: 77956020082     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(10)70010-0     Document Type: Article

References (37)

1. Alberts, B. (1.998). The cell as a collection of protein machines: Preparing the next generation of molecular biologists. Cell 92, 291-294.
2. Baba, T., et al. (2006). Construction of Escherichia coli K.-12 in-frame, single-gene knockout mutants: The Keio collection. Mol. Syst. Biol. 2, 2006.0008.
3. Ben-Aroya, S., et al. (2008). Toward a comprehensive temperature- sensitive mutant repository of the essential genes of Saccharomyces cerevisiae. Mol. Cell 30, 248-258.
4. Birrell, G. W., et al. (2002). Transcriptional response of Saccharomyces cerevisiae to DNAdamaging agents does not identify the genes that protect against these agents. Proc. Natl. Acad. Sci. USA 99, 8778-8783.
5. Brachmann, C. B., et al. (1998). Designer deletion strains derived from Saccharomyces cerevisiae S288C: A useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast 14, 115-132.
6. Breslow, D. K., et al. (2008). A comprehensive strategy enabling high-resolution functional analysis of the yeast genome. Nat. Methods 5, 711-718.
7. Butcher, R. A. andSchreiber, S. L. (2006). A microarray-based protocol for monitoring the growth of yeast overexpression strains. Nat. Protoc. 1, 569-576.
8. Deutschbauer, A. M., et al. (2005). Mechanisms of haploinsufficiency revealed by genomewide profiling in yeast. Genetics 169, 1915-1925.
9. Ericson, E., et al. (2008). Off-target effects of psychoactive drugs revealed by genome-wide assays in yeast. PLoS Genet. 4, e1000151.
10. Ghose, A. K., et al. (1999). A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J. Comb. Chem. 1, 55-68.
11. Giaever, G., et al. (1999). Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat. Genet. 21, 278-283.
12. Giaever, G., et al. (2002). Functional profiling of the Saccharomyces cerevisiae genome. Nature 418, 387-391.
13. Giaever, G., et al. (2004). Chemogenomic profiling: Identifying the functional interactions of small molecules in yeast. Proc. Natl. Acad. Sci. USA 101, 793-798.
14. Gietz, R. D., andSchiestl, R. H. (2007). Large-scale high-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nur. Protoc. 2, 38-41.
15. Hillenmeyer, M. E., et al. (2008). The chemical genomic portrait of yeast: Uncovering a phenotype for all genes. Science 320, 362-365.
16. Ho, C. H., et al. (2009). A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds. Nat. Biotechnol. 27, 369-377.
17. Hoon, S., et al. (2008). An integrated platform of genomic assays reveals small-molecule bioactivities. Nat. Chem. Biol. 4, 498-506.
18. Jones, G. M., et al. (2008). A systematic library for comprehensive overexpression screens in Saccharomyces cerevisiae. Nat. Methods 5, 239-241.
19. Kastenmayer, J. P., et al. (2006). Functional genomics of genes with small open reading frames (sORFs) in S. cerevisiae. Genome Res. 16, 365-373.
20. Kitagawa, M., et al. (2005). Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): Unique resources for biological research. DNA Res. 12, 291-299.
21. Lee, W., et al. (2005). Genome-wide requirements for resistance to functionally distinct DNA-damaging agents. PLoS Genet. 1, e24.
22. Lurn, P. Y., et al. (2004). Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 116, 121-137.
23. Luo, B., et al. (2008). Highly parallel identification of essential genes in cancer cells. Proc. Natl. Acad. Sci. USA. 105, 20380-20385.
24. Moffat, J., et al. (2006). A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen, Cell 124, 1283-1298.
25. Nislow, C. andGiaever, G. (2007). Chemical Genomic Tools for Understanding Gene Function and Drug Action. Methods in Microbiology 36, 387-414, 708-709.
26. Ooi, S. L., et al. (2001). A DNA microarray-based genetic screen for nonhomologous endjoining mutants in Saccharomyces cerevisiae. Science 294, 2552-2556.
27. Pan, X., et al. (2004). A. robust toolkit for functional profiling of the yeast genome. Mol. Cell 16, 487-496.
28. Parsons, A. B., et al. (2004). Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat. Biotechnol. 22, 62-69.
29. Parsons, A. B., et al. (2006). Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 126, 611-625.
30. Pierce, S. E., et al. (2006). A unique and universal molecular barcode array. Nat. Methods 3, 601-603.
31. Rine, J., et al. (1.983). Targeted selection of recombinant clones through gene dosage effects. Proc. Natl. Acad. Sci. USA 80, 6750-6754.
32. Shoemaker, D. D., et al. (1996). Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy. Nat. Genet. 14, 450-456.
33. Smith, A. M., et al. (2009). Quantitative phenotyping via deep barcode sequencing. Genome Res. 19, 1836-1842.
34. Steinmetz, L. M., et al. (2002). Systematic screen for human disease genes in yeast. Nat. Genet. 31, 400-404.
35. Winzeler, E. A., et al. (1999). Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285, 901-906.
36. Yan, Z., et al. (2008). Yeast Barcoders: A chemogenomic application of a universal donorstrain collection carrying bar-code identifiers. Nat. Methods 5, 719-725.
37. Yuan, D. S., et al. (2005). Improved microarray methods for profiling the Yeast Knockout strain collection. Nucleic Acids Res. 33, e103.